HTML from...
URL: https://geoegl.msp.gouv.qc.ca/igo2/apercu-qc/?context=avp
The Canada Vigilance Program collects and assesses reports of suspected adverse reactions to marketed health products in Canada, including prescription and non-prescription medications; natural health products; biologically derived products such as vaccines and fractionated blood products; cells, tissues and organs; radiopharmaceuticals; and disinfectants and sanitizers with disinfectant claims.
There are no views created for this resource yet.
Additional Information
| Field | Value |
|---|---|
| Data last updated | January 16, 2026 |
| Metadata last updated | January 20, 2026 |
| Created | January 16, 2026 |
| Format | HTML |
| License | License not specified |
| Datastore active | False |
| Has views | False |
| Id | c3f540d4-89dc-4c5d-8979-190595c29384 |
| Package id | a79a78a9-8c4a-4070-bf3f-51228afbc74e |
| Position | 0 |
| State | active |